Caricamento...
Intravitreal Controlled Release of Dexamethasone from Engineered Microparticles of Porous Silicon Dioxide
Dexamethasone is a glucocorticoid that is widely used in the ophthalmic arena. The recent FDA approved dexamethasone implant can provide a three month efficacy but with high rate of drug related cataract and high intraocular pressure (IOP). It seems that higher steroid in aqueous humor and around le...
Salvato in:
| Pubblicato in: | Exp Eye Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4259850/ https://ncbi.nlm.nih.gov/pubmed/25446320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exer.2014.11.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|